D

Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017

Watchlist Manager
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
Watchlist
Price: 58.2 SAR 1.93% Market Closed
Market Cap: ﷼9B

P/FCFE

-100.5
Current
1 204%
More Expensive
vs 3-y average of -7.7

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
-100.5
=
Market Cap
﷼9B
/
Free Cash Flow to Equity
﷼-89.4m

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
-100.5
=
Market Cap
﷼9B
/
Free Cash Flow to Equity
﷼-89.4m

Valuation Scenarios

Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC is trading above its industry average

If P/FCFE returns to its Industry Average (48.3), the stock would be worth ﷼-27.98 (148% downside from current price).

Statistics
Positive Scenarios
0/2
Maximum Downside
-148%
Maximum Upside
No Upside Scenarios
Average Downside
137%
Scenario P/FCFE Value Implied Price Upside/Downside
Current Multiple -100.5 ﷼58.2
0%
Industry Average 48.3 ﷼-27.98
-148%
Country Average 25.2 ﷼-14.61
-125%

Forward P/FCFE
Today’s price vs future free cash flow to equity

Not enough data available to calculate forward P/FCFE

Peer Comparison

All Multiples
P/FCFE
P/E
All Countries
Close

Market Distribution

Lower than 100% of companies in Saudi Arabia
Percentile
0th
Based on 176 companies
0th percentile
-100.5
Low
1.2 — 16.8
Typical Range
16.8 — 44.6
High
44.6 —
Distribution Statistics
Saudi Arabia
Min 1.2
30th Percentile 16.8
Median 25.2
70th Percentile 44.6
Max 11 988.3

Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Glance View

Market Cap
9B SAR
Industry
Health Care

In the bustling hub of healthcare innovation within the Kingdom of Saudi Arabia, Dr. Soliman Abdel Kader Fakeeh Hospital Company SCJSC stands out as a beacon of medical excellence and pioneering spirit. Founded to address the rising demand for quality healthcare services in the region, the company has grown from a single hospital into a comprehensive network of medical facilities. The core of its operations revolves around providing a full spectrum of healthcare services ranging from basic outpatient treatments to intricate surgical procedures and specialty care. The company integrates advanced medical technologies with a patient-focused care approach, ensuring that the population it serves receives both cutting-edge and compassionate treatment. Within its walls, dedicated teams of healthcare professionals work tirelessly to uphold a legacy of trust and expertise, attracting both local and international patients seeking superior medical attention. Financially, Dr. Soliman Abdel Kader Fakeeh Hospital Company operates through a multifaceted model that revolves around patient services, strategic partnerships, and insurance collaborations. By catering to a diverse array of medical needs, the company secures a steady revenue stream from its inpatient and outpatient services. Moreover, it has established alliances with various insurance companies, streamlining the payment processes for insured patients and enhancing financial access to healthcare services. Strategic expansions and the introduction of specialized units also contribute significantly to its revenue, allowing it to capture more market share and cater to niche medical needs. The organization's business acumen is evident in its ability to balance quality care with economic sustainability, ensuring its growth while maintaining high standards of healthcare delivery across the kingdom.

Intrinsic Value
43.15 SAR
Overvaluation 26%
Intrinsic Value
Price ﷼58.2
D
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett